ProShare Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
|
|||||
|
2025
Q1 | $303K | Sell |
|
|||||
|
2024
Q4 | $438K | Buy |
|
|||||
|
2024
Q3 | $336K | Buy |
|
|||||
|
2024
Q2 | $171K | Sell |
|
|||||
|
2024
Q1 | $259K | Buy |
|
|||||
|
2023
Q4 | $81.6K | Buy |
|
|||||
|
2023
Q3 | $48.1K | Buy |
|
|||||
|
2023
Q2 | $78.3K | Buy |
|
|||||
|
2023
Q1 | $75.9K | Sell |
|
|||||
|
2022
Q4 | $45.8K | Buy |
|
|||||
|
2022
Q3 | $62K | Buy |
|
|||||
|
2022
Q2 | $59K | Sell |
|
|||||
|
2022
Q1 | $111K | Sell |
|
|||||
|
2021
Q4 | $192K | Buy |
|
|||||
|
2021
Q3 | $262K | Sell |
|
|||||
|
2021
Q2 | $476K | Buy |
|
|||||
|
2021
Q1 | $490K | Buy |
|
|||||
|
2020
Q4 | $543K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $53K | Buy |
|
|||||
|
2019
Q2 | $72K | Sell |
|
|||||
|
2019
Q1 | $71K | Buy |
|
|||||
|
2018
Q4 | $69K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $120K | Sell |
|
|||||
|
2016
Q2 | $102K | Buy |
|
|||||
|
2016
Q1 | $193K | Sell |
|
|||||
|
2015
Q4 | $207K | Buy |
|